NCT05929950尚未招募不适用
The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- measuring serum anti-ovarian, anti-nuclear, anti-double stranded and anti-thyroid antibodies
研究概览
简要总结
The goal of the study is to detect autoantibodies in the serum of the women with PCOS and evaluate the obesity markers to investigate the the role of autoimmunity and obesity in PCOS
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 12 Years 至 55 Years（Child, Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •patients diagnosed with PCOS according to the Rotterdam (2003) criteria.
排除标准
- •Patients with other causes of hyperandrogenism as congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, virilizing ovarian or adrenal tumors and those taking drugs affecting insulin resistance, such as estrogens, oral contraceptives and corticosteroids during the previous three months before the study.
结局指标
主要结局
measuring serum anti-ovarian, anti-nuclear, anti-double stranded and anti-thyroid antibodies
时间窗: 3 months after recruitment
Theses markers will be measured using ELISA technique
次要结局
未报告次要终点
研究者
Ola Ahmed Hamed
Assistant lecturer
Sohag University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
PCOS Patients' Immune AlterationsPolycystic Ovary SyndromMetforminImmune FunctionNCT06325969Shanghai 10th People's Hospital162
Unknown
不适用
Metabolic Disorders in Polycystic Ovarian SyndromePolycystic Ovary SyndromeNCT00172523National Taiwan University Hospital
已完成
1 期
Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)Polycystic Ovary SyndromeNCT02086526Mayo Clinic68
已完成
不适用
Obesity and Clinical Presentation of HyperandrogenismPolycystic Ovary SyndromeNCT01114633Taipei Medical University WanFang Hospital46
已完成
不适用
Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese ControlsPolycystic Ovary SyndromeNCT05468476Zhang Manna121